• LAST CALL: OUR BEST DEAL EXPIRES SOON!

    SAVE UP TO 66% OFF

    MACRO & STOCK-PICKING ESSENTIALS

Hedgeye CEO Keith McCullough is adding 1Life Healthcare (ONEM) to the long side of Investing Ideas. Below is a brief note.

Buying things on sale isn't that complicated. Having patience while the crowd has FOMO can be... 

Looking for stocks that are down on decelerating volume into the close? 1Life Healthcare (ONEM) is one of Tom Tobin's latest Best Ideas (Institutional Research product).

Here's the summary intro the idea he presented recently:

ONEM fits the post-COVID re-opening theme we've been working on most recently.  COVID-19 will continue to impact how we work, shop, and travel, but may impact how we get medical care most of all.  One recent survey suggested 41% of consumers "are concerned about being able to see their doctor in a safe environment" while 11% of physicians will leave medical care altogether.  Our thesis is not that ONEM won't be impacted, it will, but as these changes to care patterns emerge, we expect ONEM will be a net beneficiary.  As we'll show, the count and penetration of corporate customers in their existing markets remains low and these high income firms will need  help to reopen and help keeping employees both safe and feeling safe.  We'll also show how we plan to track physicians leaving patient care and the potential to dramatically increase ONEM's market share as well.

The stock is -7% here and that's a nice sale to buy into,

KM